TY - JOUR

T1 - Illness management and recovery

T2 - one-year follow-up of a randomized controlled trial in Danish community mental health centers: long-term effects on clinical and personal recovery

AU - Jensen, Sofie Bratberg

AU - Dalum, Helle Stentoft

AU - Korsbek, Lisa

AU - Hjorthøj, Carsten

AU - Mikkelsen, John Hagel

AU - Thomsen, Karin

AU - Kistrup, Kristen

AU - Olander, Mette

AU - Lindschou, Jane

AU - Mueser, Kim T

AU - Nordentoft, Merete

AU - Eplov, Lene Falgaard

PY - 2019

Y1 - 2019

N2 - BACKGROUND: Illness Management and Recovery (IMR) is a curriculum-based rehabilitation program for people with severe mental illness with the short-term aim of improving illness self-management and the long-term aim of helping people achieve clinical and personal recovery.METHOD: Participants with schizophrenia or bipolar disorders were recruited from three community mental health centers in the Capital Region of Denmark and randomized to receive group-based IMR and treatment as usual or only the usual intervention. All outcomes were assessed at baseline, postintervention, and the one-year follow-up. Long-term outcomes were categorized according to clinical recovery (i.e., symptoms, global functioning, and hospitalization) and personal recovery (i.e., hope and personal agency). Generalized linear mixed model regression analyses were used in the intent-to-treat analysis.RESULTS: A total of 198 participants were included. No significant differences were found between the IMR and control groups in the Global Assessment of Functioning one year after the intervention, nor were there significant differences in symptoms, number of hospital admissions, emergency room visits, or outpatient treatment.CONCLUSION: The present IMR trial showed no significant effect on clinical and personal recovery at the one-year follow-up. Together with the results of other IMR studies, the present study indicates that the effect of IMR on symptom severity is unclear, which raises questions regarding the impact of IMR on functioning. Additionally, IMR did not affect personal recovery. Although more research is needed, the results indicate that the development of other interventions should be considered to help people with severe mental illness achieve a better level of functioning and personal recovery.TRIAL REGISTRATION: Trial registered at http://www.clinicaltrials.gov ( NCT01361698 ).

AB - BACKGROUND: Illness Management and Recovery (IMR) is a curriculum-based rehabilitation program for people with severe mental illness with the short-term aim of improving illness self-management and the long-term aim of helping people achieve clinical and personal recovery.METHOD: Participants with schizophrenia or bipolar disorders were recruited from three community mental health centers in the Capital Region of Denmark and randomized to receive group-based IMR and treatment as usual or only the usual intervention. All outcomes were assessed at baseline, postintervention, and the one-year follow-up. Long-term outcomes were categorized according to clinical recovery (i.e., symptoms, global functioning, and hospitalization) and personal recovery (i.e., hope and personal agency). Generalized linear mixed model regression analyses were used in the intent-to-treat analysis.RESULTS: A total of 198 participants were included. No significant differences were found between the IMR and control groups in the Global Assessment of Functioning one year after the intervention, nor were there significant differences in symptoms, number of hospital admissions, emergency room visits, or outpatient treatment.CONCLUSION: The present IMR trial showed no significant effect on clinical and personal recovery at the one-year follow-up. Together with the results of other IMR studies, the present study indicates that the effect of IMR on symptom severity is unclear, which raises questions regarding the impact of IMR on functioning. Additionally, IMR did not affect personal recovery. Although more research is needed, the results indicate that the development of other interventions should be considered to help people with severe mental illness achieve a better level of functioning and personal recovery.TRIAL REGISTRATION: Trial registered at http://www.clinicaltrials.gov ( NCT01361698 ).

U2 - 10.1186/s12888-019-2048-0

DO - 10.1186/s12888-019-2048-0

M3 - Journal article

C2 - 30744590

VL - 19

JO - B M C Psychiatry

JF - B M C Psychiatry

SN - 1471-244X

M1 - 65

ER -